Login

Market News

Axon Enterprise, Inc.

A $1.2 billion Skydio stake and federal delays headline the quarter's strategy shifts.

Onconetix Inc

As previously disclosed, on February 11, 2026, Onconetix, Inc., a Delaware corporation ("Onconetix" or "Buyer"), entered into a Share ...

VEON Ltd

2026-11-06. The following slide deck was published by VEON Ltd.

REF

BTIG analyst Janine Stichter maintains Reformation (NYSE:REF) with a Buy and raises the price target from $20 to $21.

PDF Solutions, Inc.

Record revenue and margin expansion, plus a new AI analytics launch.

CSG NV

Through MSM North America, CSG has been selected as one of the U.S. Army's qualified contractors eligible to compete for ammunition plant modernizatio...

Guardant Health, Inc.

Shield cost per test beat its target early while screening guidance moved higher.

JFrog Ltd.

Cloud momentum accelerated sharply, and management says AI is reshaping software supply chains.

Savers Value Village, Inc.

Canadian margins grew as new pricing and labor technology rolled out.

Emergent BioSolutions Inc.

Emergent BioSolutions faces margin pressure, lowered FY26 guidance, and weak profitability despite cost cuts. Learn more about EBS stock here.

Utz Brands, Inc.

Utz Brands (NYSE:UTZ) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.23 by 56.52 percent. This is a ...

Elanco Animal Health Incorporated

Elanco Animal Health (NYSE:ELAN) is looking for Q4 Adj EPS of $0.16-$0.19 vs $0.18 analyst estimate. sees sales of $1.190 billion-$1.215 billion vs $1...

Elanco Animal Health Incorporated

Elanco Animal Health (NYSE:ELAN) raises FY2026 Adj EPS guidance from $1.10-$1.16 to $1.17-$1.20 vs $1.13 analyst estimate. Raises FY2026 sales outlook...

Navitas Semiconductor Corporation

Navitas Semiconductor Corporation remains a Hold as 2027 AI growth outlook improves, but valuations are still demanding. Read more on NVTS stock here.

Innodata Inc.

Revenue hit a record despite a major program loss at its largest customer.

BETA Technologies, Inc.

BTIG analyst Andre Madrid reiterates BETA Technologies (NYSE:BETA) with a Buy and maintains $33 price target.

PAR Technology Corporation

Management raised its full-year outlook, but warned fourth-quarter cash flow will be softer.

Eton Pharmaceuticals Inc

Rare disease specialist posts record margins and raises outlook.

eGain Corp

Legacy runoff weighed on results, but AI now drives most ARR.

< Prev Page 229 of 107688 Next >

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support